184 related articles for article (PubMed ID: 23746695)
1. Interaction of EGFR with the tumour microenvironment: implications for radiation treatment.
Nijkamp MM; Span PN; Bussink J; Kaanders JH
Radiother Oncol; 2013 Jul; 108(1):17-23. PubMed ID: 23746695
[TBL] [Abstract][Full Text] [Related]
2. Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results.
Baumann M; Krause M
Radiother Oncol; 2004 Sep; 72(3):257-66. PubMed ID: 15450723
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of disease: Radiosensitization by epidermal growth factor receptor inhibitors.
Sartor CI
Nat Clin Pract Oncol; 2004 Dec; 1(2):80-7. PubMed ID: 16264825
[TBL] [Abstract][Full Text] [Related]
4. EGFR-targeted anti-cancer drugs in radiotherapy: preclinical evaluation of mechanisms.
Baumann M; Krause M; Dikomey E; Dittmann K; Dörr W; Kasten-Pisula U; Rodemann HP
Radiother Oncol; 2007 Jun; 83(3):238-48. PubMed ID: 17502118
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor and tumor response to radiation: in vivo preclinical studies.
Milas L; Fan Z; Andratschke NH; Ang KK
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):966-71. PubMed ID: 14967457
[TBL] [Abstract][Full Text] [Related]
6. The epidermal growth factor receptor: a role in repair of radiation-induced DNA damage.
Chen DJ; Nirodi CS
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6555-60. PubMed ID: 18006754
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathways: emerging pathways mediating growth, invasion, and metastasis of tumors progressing in an irradiated microenvironment.
Kuonen F; Secondini C; Rüegg C
Clin Cancer Res; 2012 Oct; 18(19):5196-202. PubMed ID: 22730447
[TBL] [Abstract][Full Text] [Related]
8. Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCC.
Krause M; Schütze C; Petersen C; Pimentel N; Hessel F; Harstrick A; Baumann M
Radiother Oncol; 2005 Feb; 74(2):109-15. PubMed ID: 15734198
[TBL] [Abstract][Full Text] [Related]
9. Microenvironmental transformations by VEGF- and EGF-receptor inhibition and potential implications for responsiveness to radiotherapy.
Bussink J; Kaanders JH; van der Kogel AJ
Radiother Oncol; 2007 Jan; 82(1):10-7. PubMed ID: 17141899
[TBL] [Abstract][Full Text] [Related]
10. Combining EGFR inhibitors with radiation or chemotherapy: will preclinical studies predict clinical results?
Harari PM; Huang SM
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):976-83. PubMed ID: 14967459
[TBL] [Abstract][Full Text] [Related]
11. Chemical radiosensitizers for use in radiotherapy.
Wardman P
Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):397-417. PubMed ID: 17478086
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor biology in head and neck cancer.
Kalyankrishna S; Grandis JR
J Clin Oncol; 2006 Jun; 24(17):2666-72. PubMed ID: 16763281
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxia.
Marie-Egyptienne DT; Lohse I; Hill RP
Cancer Lett; 2013 Nov; 341(1):63-72. PubMed ID: 23200673
[TBL] [Abstract][Full Text] [Related]
14. Diverse effects of combined radiotherapy and EGFR inhibition with antibodies or TK inhibitors on local tumour control and correlation with EGFR gene expression.
Gurtner K; Deuse Y; Bütof R; Schaal K; Eicheler W; Oertel R; Grenman R; Thames H; Yaromina A; Baumann M; Krause M
Radiother Oncol; 2011 Jun; 99(3):323-30. PubMed ID: 21665304
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of tumour response to combined radiotherapy and EGFR inhibitors: differences between antibodies and TK inhibitors.
Krause M; Gurtner K; Deuse Y; Baumann M
Int J Radiat Biol; 2009 Nov; 85(11):943-54. PubMed ID: 19895271
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor family receptors and inhibitors: radiation response modulators.
Sartor CI
Semin Radiat Oncol; 2003 Jan; 13(1):22-30. PubMed ID: 12520461
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial.
Bentzen SM; Atasoy BM; Daley FM; Dische S; Richman PI; Saunders MI; Trott KR; Wilson GD
J Clin Oncol; 2005 Aug; 23(24):5560-7. PubMed ID: 16110017
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor and its inhibition in radiotherapy: in vivo findings.
Milas L; Mason KA; Ang KK
Int J Radiat Biol; 2003 Jul; 79(7):539-45. PubMed ID: 14530163
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trials.
Magné N; Chargari C; Castadot P; Ghalibafian M; Soria JC; Haie-Meder C; Bourhis J; Deutsch E
Eur J Cancer; 2008 Oct; 44(15):2133-43. PubMed ID: 18692389
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor expression and activation in neuroendocrine tumours.
Shah T; Hochhauser D; Frow R; Quaglia A; Dhillon AP; Caplin ME
J Neuroendocrinol; 2006 May; 18(5):355-60. PubMed ID: 16629834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
